Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers. (Q42222443)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763132%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

title

Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763132%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763132%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Tung-Hung Su

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763132%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Jia-Horng Kao

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763132%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

author name string

Chun-Jen Liu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763132%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Hung-Chih Yang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763132%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Chi-Ling Chen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763132%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Wan-Ting Yang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763132%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Cheng-Shiue Tsai

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763132%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Stephanie Fang-Tzu Kuo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763132%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Femke Carolien Verbree

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763132%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Chia-Chi Wang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763132%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Chen-Hua Liu

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763132%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Pei-Jer Chen

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763132%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Ding-Shinn Chen

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763132%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

language of work or name

English

0 references

publication date

24 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763132%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763132%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763132%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

page(s)

292-302

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763132%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763132%20AND%20SRC:MED&resulttype=core&format=json

Fighting against viral hepatitis: lessons from Taiwan.

15 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

Hepatitis B virus genotypes and hepatocellular carcinoma in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

Predicting cirrhosis risk based on the level of circulating hepatitis B viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

Quantitative dynamics of hepatitis B basal core promoter and precore mutants before and after HBeAg seroconversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

Young Chronic Hepatitis B Patients With Nucleos(t)ide Analogue-induced Hepatitis B e Antigen Seroconversion Have a Higher Risk of HBV Reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

Chronic hepatitis B: update 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

Hepatitis B virus core variants modify natural course of viral infection and hepatocellular carcinoma progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

Basal core promoter mutation is associated with progression to cirrhosis rather than hepatocellular carcinoma in chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

Hepatitis B virus core promoter mutations contribute to hepatocarcinogenesis by deregulating SKP2 and its target, p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977

The hepatitis B virus X protein induces paracrine activation of human hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-306977